QualityStocksNewsBreaks Archives - Page 1105 of 1544

ThursdayJan 30, 2020 11:45 am

QualityStocksNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Plans to Release Benchtop UST-Based BaroShear Instrument in Q3 2020

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its plans to release a benchtop, R&D scale, Ultra Shear Technology(TM) (“UST”)-based BaroShear instrument to the market in the third quarter of 2020. Per the update, Pressure BioSciences believes this new instrument will address a significant un-met need in product formulation and development laboratories throughout cannabis, cosmetics, nutraceuticals, pharmaceuticals, and other large and diverse markets for processing CBD and other oils into stable, effectively water-soluble, highly absorbable nanoemulsions of…

ThursdayJan 30, 2020 11:18 am

QualityStocksNewsBreaks – CloudCommerce, Inc. (CLWD) Awarded Additional Contracts from Large Public Utility

CloudCommerce (OTCQB: CLWD), a leading provider of data driven marketing solutions, today announced that it has been awarded two new contracts from an existing client. According to the update, the new contracts from a large public utility demonstrate that CloudCommerce’s proprietary SWARM solution is effectively driving measurable ROI across multiple divisions of the client’s organization. “The client’s marketing challenge was to expand its reach into new market areas, increase the number of qualified sales leads and decrease the cost of customer acquisition,” CloudCommerce CEO Andrew Van Noy said in the news release. “This is a tall order and a nearly…

ThursdayJan 30, 2020 10:30 am

QualityStocksNewsBreaks – Endonovo Therapeutics, Inc. (ENDV) Receives SofPulse(R) Orders From Multiple Plastic Surgery Centers

Endonovo Therapeutics (OTCQB: ENDV) today announced that it has secured sales of SofPulse(R), the company’s FDA-Cleared, non-invasive device utilized for the reduction of postoperative pain and edema, to multiple plastic surgery centers. “SofPulse(R) main distribution model is marketing to major hospitals throughout the US and is beginning to be viewed as the standard of care for postoperative pain and edema reduction for numerous inpatient hospital procedures. With the expansion of our customer base and recent orders from numerous plastic surgery centers, SofPulse(R) demonstrates different applications for its use,” Endonovo Therapeutics CEO Alan Collier stated in the news release. “We are…

ThursdayJan 30, 2020 9:51 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Foresight Affiliate Rail Vision in Advanced Negotiations with Leading European Train Operator for First Commercial Agreement

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that its affiliate, Rail Vision Ltd., is in advanced negotiations regarding its first commercial agreement with a leading European train operator. The agreement contemplates the purchase of a prototype system of Rail Vision’s shunting yard solution for a total value of approximately 500,000 Euro and, upon successful prototype evaluation, will entail the purchase of approximately 30 more shunting yard systems for an additional 2.5 million Euro. In addition, the European train operator may exercise its option to purchase an additional 45 shunting yard systems for…

WednesdayJan 29, 2020 1:52 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Technology Accelerates Delivery of CBD into Bloodstream

Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) 2.0 version of its patented DehydraTECH(TM) oral drug-delivery technology has demonstrated its power to deliver more cannabidiol (“CBD”) into the bloodstream than generic industry-control formulations (http://ibn.fm/Utl7A). An article discussing the company reads, “The company’s 2.0 technology is specifically being developed for effectiveness in helping to deliver its drug payload across the blood-brain barrier, a natural biological system of blood vessels and endothelial cells that bar most drugs from accessing the brain’s central-nervous-system hierarchy. The ability to effectively deliver drugs to the brain is of keen interest to developers of drugs designed to beneficially target…

WednesdayJan 29, 2020 1:45 pm

QualityStocksNewsBreaks – ChineseInvestors.com Inc. (CIIX) Advancing CBD Initiatives

ChineseInvestors.com (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States and China, is capitalizing on the rising demand for cannabidiol (“CBD”)-based nutrition and health products. A recent article discussing the company reads, “CIIX’s CBD initiatives are carried out by its subsidiary, CBD Biotech Inc. In essence, CIIX is taking advantage of its own financial expertise to establish itself as a leader in China’s developing CBD industry. Through CBD Biotech, CIIX has established a three-year development plan to capitalize on the union of CBD and the nutrition and health-products market in mainland China. . . .…

WednesdayJan 29, 2020 10:51 am

QualityStocksNewsBreaks – Sugarmade, Inc. (SGMD) Announces New, Bold Shift in Business Strategy, Eyes On-Demand Revolution of the Cannabis Sector

Sugarmade (OTCQB: SGMD) today announced a new and bold shift in its business strategy toward the virtualization of the cannabis sector as part of the major shift in the U.S. business model toward an on-demand economy. According to the update, Sugarmade will make several strategic moves over the coming weeks as it launches on-demand and related business operations via internally developed initiatives and new relationships with proven sector business operators. “Things are changing in society and in the economy as virtualization proliferates. Many of the most dynamic and innovative growth companies are part of this on-demand revolution and it is…

WednesdayJan 29, 2020 10:15 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Independent Research Findings on TUSC2 as a Potential Target and Biomarker for Thyroid Carcinoma

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that, in a recent study, independent researchers reported that TUSC2, a tumor suppressor gene and the active agent in Genprex’s Oncoprex(TM) immunogene therapy, is a potential target and biomarker for thyroid carcinoma. Genprex has no affiliation with these researchers. The study, published in the International Journal of Molecular Sciences, reports that TUSC2 overexpression decreased thyroid cancer proliferation, migration and invasion. “We continue to be encouraged by data resulting from studies conducted at multiple research institutions…

WednesdayJan 29, 2020 9:48 am

QualityStocksNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Closes Deal to Purchase Hemp Extraction Company Kase Farma Inc.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), a hemp-biomass processing entity, this morning announced the closing of its previously announced share and purchase agreement (“SPA”) with Starling Brands, Inc., a party at arm's length to HTC, pursuant to which HTC purchased all the issued and outstanding shares of Kase Farma Inc. Kase Farma, which is authorized to operate in the areas of hemp cultivation, extraction, refining and formulation in the State of California, is now a wholly owned subsidiary of HTC. In accordance with the agreement, the company retains the management services of Starling, led by highly regarded experts in…

WednesdayJan 29, 2020 9:30 am

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) CEO Enters Voluntary Escrow Agreement; Plans to Hold Shares for Minimum of 12 Months

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) this morning announced that CEO and largest shareholder Kelly Jennings is entering into a voluntary escrow agreement with Computershare and reported that he will not sell his shares for at least 12 months, until January 29, 2021. This commitment is additional to any escrow imposed by the TSX Venture Exchange. Jennings holds 41,865,283 shares of PowerBand, representing about 37% of the company's outstanding shares. “I want people to know I am invested in PowerBand for the long run as we revolutionize how cars and trucks are bought, sold, leased and auctioned,” PowerBand…

Site Search

Company Search

Category: QualityStocksNewsBreaks